Comparison CompoundClassPathway / targetResearch focusFormat BPC-157Gastric pentadecapeptideCytoprotection / angiogenesisGut & soft-tissue repairVial TB-500Thymosin beta-4 peptideActin binding / cell migrationWound & tendon repairVial TB-500 (Frag)Thymosin beta-4 fragmentActin-binding domainCell migration researchVial BPC-157 + TB-500Peptide blendCytoprotection + actin signallingCombined repair researchVial GLOWPeptide blendCopper-peptide + repair peptidesDermal & connective-tissue researchVial KLOWPeptide blendRepair peptides + anti-inflammatoryCombined repair & inflammation researchVial BPC-157 Arginate CapsulesGastric pentadecapeptide (salt form)Cytoprotection / angiogenesisOral-route repair researchCapsules BPC-157 Arginate + TB-500 CapsulesPeptide blend (salt form)Cytoprotection + actin signallingOral-route combined researchCapsules TB-500 CapsulesThymosin beta-4 peptideActin binding / cell migrationOral-route repair researchCapsules Every compound in this category is supplied as Research Use Only material with: Peer-reviewed literature underpinning this category
Increased iron stores also may increase the risk of breast cancer
Problem: No noticeable effect Possible causes: Dose too low for your neurochemistry Product quality issues (underdosed or degraded) Timing not optimal for your sleep patterns Individual non-response to DSIP Solutions: Increase dose by 25-50% increments over several days Try a different vendor or batch Experiment with different timing windows If no response at 250mcg with confirmed quality product, DSIP may not work for you Problem: Initial effects that faded Possible causes: Tolerance development from excessive frequency Product degradation over time Changes in baseline sleep (improvement making DSIP less noticeable) Solutions: Take a 2-4 week break and reassess Check reconstitution date and prepare fresh solution Reduce frequency to prevent tolerance Consider whether improved sleep fundamentals may have reduced DSIP's relative impact Problem: Inconsistent results Possible causes: Variable timing or dosing Lifestyle factors interfering (stress, caffeine, irregular schedule) Injection technique inconsistency Solutions: Standardize protocol: same dose, same time, same technique Address confounding factors: caffeine cutoff 8+ hours before bed, consistent wake times Ensure consistent subcutaneous depth and injection sites Problem: Too much sedation or next-day grogginess Possible causes: Dose too high Timing too close to bedtime Interaction with other substances Solutions: Reduce dose by 25-50% Administer earlier in the evening (2-3 hours before bed) DSIP dosage compared to other sleep peptides Understanding how DSIP compares to other sleep-promoting peptides helps you choose the right tool for your situation
Manufacturing is unregulated Solvent residues may remain Purity is unverified Sterility is not assured 3
The raw m Sichuan Hantong Kuntai was established in 2025
Most protocols recommend morning injection
